119 related articles for article (PubMed ID: 7132558)
21. In vivo [3H]spiperone binding: evidence for accumulation in corpus striatum by agonist-mediated receptor internalization.
Chugani DC; Ackermann RF; Phelps ME
J Cereb Blood Flow Metab; 1988 Jun; 8(3):291-303. PubMed ID: 2966803
[TBL] [Abstract][Full Text] [Related]
22. Pre- and postnatal ontogeny and characterization of dopaminergic D2, serotonergic S2, and spirodecanone binding sites in rat forebrain.
Bruinink A; Lichtensteiger W; Schlumpf M
J Neurochem; 1983 May; 40(5):1227-36. PubMed ID: 6834058
[TBL] [Abstract][Full Text] [Related]
23. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
Lazareno S; Nahorski SR
Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
[TBL] [Abstract][Full Text] [Related]
24. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
Levant B; Grigoriadis DE; DeSouza EB
J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
[TBL] [Abstract][Full Text] [Related]
25. Competitive inhibition of [3H]spiperone binding to D-2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cations.
De Vries DJ; Beart PM
Eur J Pharmacol; 1984 Oct; 106(1):133-9. PubMed ID: 6241565
[TBL] [Abstract][Full Text] [Related]
26. 4-[123I]iodospiperone as a ligand for dopamine DA receptors: in vitro and in vivo experiments in a rat model.
Van der Krogt JA; Pauwels EK; Van Doremalen PA; Wijnhoven G; Reiffers S; Van Valkenburg CF; Buruma OJ
Int J Rad Appl Instrum B; 1992 Oct; 19(7):759-63. PubMed ID: 1399697
[TBL] [Abstract][Full Text] [Related]
27. Chronic proglumide increases [3H]spiperone binding in the rat brain.
Bean AJ; Baldy WJ; Martin GE
Eur J Pharmacol; 1985 Oct; 117(1):97-101. PubMed ID: 4085545
[TBL] [Abstract][Full Text] [Related]
28. Chronic ACTH treatment increases striatal dopamine D-2 receptor binding in developing rat brain.
Chiriboga CA; Pranzatelli MR; De Vivo DC
Brain Dev; 1989; 11(3):197-200. PubMed ID: 2546461
[TBL] [Abstract][Full Text] [Related]
29. Dopamine receptors in human foetal brains: characterization, regulation and ontogeny of [3H]spiperone binding sites in striatum.
Kumar BV; Sastry PS
Neurochem Int; 1992 Jun; 20(4):559-66. PubMed ID: 1304871
[TBL] [Abstract][Full Text] [Related]
30. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration.
Hall MD; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Oct; 32(19):2973-7. PubMed ID: 6626267
[TBL] [Abstract][Full Text] [Related]
31. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo.
Leslie CA; Bennett JP
Brain Res; 1987 Jul; 415(1):90-7. PubMed ID: 2957025
[TBL] [Abstract][Full Text] [Related]
32. Relationship between dopamine receptor occupation by spiperone and acetylcholine levels in the rat striatum after long-term haloperidol treatment depends on dopamine innervation.
Korf J; Sebens JB
J Neurochem; 1987 Feb; 48(2):516-21. PubMed ID: 2878979
[TBL] [Abstract][Full Text] [Related]
33. Magnesium ions reveal nanomolar potency of dopamine at [3H]spiperone labelled D-2 receptors in rat corpus striatum.
De Vries DJ; Beart PM
Eur J Pharmacol; 1985 Mar; 109(3):417-9. PubMed ID: 3157589
[TBL] [Abstract][Full Text] [Related]
34. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
Chatterjee TK; Scott CE; Vazquez DM; Bhatnagar RK
Mol Pharmacol; 1988 Apr; 33(4):402-13. PubMed ID: 3357484
[TBL] [Abstract][Full Text] [Related]
35. Specific binding of [11C]spiroperidol in rat brain in vivo.
Arnett CD; Fowler JS; Wolf AP; MacGregor RR
J Neurochem; 1983 Feb; 40(2):455-9. PubMed ID: 6185638
[TBL] [Abstract][Full Text] [Related]
36. Interaction of flunarizine with dopamine D2 and D1 receptors.
Ambrosio C; Stefanini E
Eur J Pharmacol; 1991 May; 197(2-3):221-3. PubMed ID: 1833208
[TBL] [Abstract][Full Text] [Related]
37. Autoradiographic localization of [3H]buspirone binding sites in rat brain.
Kaulen P; Brüning G; Schneider U; Baumgarten HG
Neurosci Lett; 1985 Jan; 53(2):191-5. PubMed ID: 3982707
[TBL] [Abstract][Full Text] [Related]
38. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
[TBL] [Abstract][Full Text] [Related]
39. Comparison of (3H)-terguride and (3H)-spiperone binding to dopamine receptors in the rat striatum.
Valchár M; Dobrovský K; Krejcí I; Dlabac A
Act Nerv Super (Praha); 1989 Apr; 31(1):77-9. PubMed ID: 2675526
[No Abstract] [Full Text] [Related]
40. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
Zahniser NR; Dubocovich ML
J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
